Endovascular management of vascular renal injuries: outcomes and comparison between traumatic and iatrogenic settings

Urologia. 2022 May;89(2):167-175. doi: 10.1177/03915603211017886. Epub 2021 May 20.

Abstract

Purpose: To evaluate the efficacy of endovascular treatment for vascular renal injuries (VRIs) like bleeding, pseudoaneurysm and artero-venous fistula (AVF) and to compare patients with blunt trauma (T-VRIs) with those with iatrogenic damage (I-VRIs).

Methods: We retrospectively assessed 49 renal artery embolizations performed to treat T-VRIs (26.5%) and I-VRIs (73.5%). Different embolic materials were used based on the type of lesion. Technical success was defined as the complete occlusion of target arteries with no further visualization of VRIs. Clinical success was defined if no recurrence was present and if renal function (difference between creatinine after and before treatment <0.5 mg/dl) was preserved after 1 month.

Results: Angiography showed bleeding in 27 patients, pseudoaneurysm in 29 and an AVF in 6. Embolic agents used were coils in 39 procedures, coils with sponge in four and others in six. Technical success was 100% while clinical success was 85.7% due to seven patients with recurrence. The group I-VRIs showed a higher rate of clinical success than the group T-VRIs (94.4% vs 61.5%; p < 0.05). Moreover, the group I-VRIs had a higher incidence of pseudoaneurysms and AVFs compared with the group T-VRIs (69.4% vs 30.8% and 16.7% vs 0%; p < 0.05).

Conclusion: Endovascular treatment for VRIs showed satisfactory results and no patient had a worsening of renal function. I-VRIs had better clinical success and more frequently appeared as pseudoaneurysms compared to T-VRIs: probably iatrogenic injury is localized and pseudoaneurysm is easily identifiable and treatable with endovascular treatment.

Keywords: Renal embolization; iatrogenic bleeding; renal hematoma; renal trauma; vascular renal injury.

MeSH terms

  • Aneurysm, False* / etiology
  • Aneurysm, False* / therapy
  • Embolization, Therapeutic* / methods
  • Endovascular Procedures* / adverse effects
  • Endovascular Procedures* / methods
  • Hemorrhage / complications
  • Hemorrhage / therapy
  • Humans
  • Iatrogenic Disease
  • Kidney / physiology
  • Retrospective Studies
  • Treatment Outcome